Correction: Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy.

Autor: He, Kewen, Puebla-Osorio, Nahum, Barsoumian, Hampartsoum B., Sezen, Duygu, Rafq, Zahid, Riad, Thomas S., Hu, Yun, Huang, Ailing, Voss, Tifany A., Kettlun Leyton, Claudia S., Schuda, Lily Jae, Hsu, Ethan, Heiber, Joshua, Cortez, Maria-Angelica, Welsh, James W.
Předmět:
Zdroj: Journal of Experimental & Clinical Cancer Research (17569966); 9/10/2024, Vol. 43 Issue 1, p1-1, 1p
Abstrakt: This document is a correction notice for an article titled "Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy." The correction addresses an error in the affiliation of the 5th author, Zahid Rafiq, who was mistakenly assigned to the wrong institution. The correct affiliation for Zahid Rafiq is the Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. The correction does not impact the overall findings or conclusions of the article. [Extracted from the article]
Databáze: Complementary Index
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje